51
Participants
Start Date
July 31, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Blood glucose monitoring
Regular pre and post meal blood glucose monitoring.
Insulin Glulisine
Sub cutaneous injection given twice daily for 3 days. Dosage titrated to body mass index and body weight (BMI \< 30 = 0.1 unit/kg. BMI \> 30 = 0.2 unit/kg)
Royal Bournemouth Hospital, Bournemouth
Collaborators (1)
Sanofi
INDUSTRY
The Royal Bournemouth Hospital
OTHER